MetAlert (OTC: MLRT), a pioneer in location-sensitive, health-monitoring devices and wearable technology products for remote patient monitoring, is reporting on its focus on and progress in the artificial intelligence (“AI”) healthcare space. According to the announcement, the company is initiating a series of RFPs and detailed discussions with potential developers and strategic partners. By doing so, the company is indicating its vision to “incorporate groundbreaking capabilities of artificial intelligence into its various technology platforms, marking this a critical pivot for the wearable healthcare sector, and commitment to fully harness the potential of artificial intelligence to help shape the future of healthcare.” The company noted that the industry is projected to reach $63 billion by 2025, and MetAlert is dedicated to doing more than simply enhancing its remote patient monitoring solutions; the company is focused on integrating AI into its products and marking a pathway that lays the foundation for predictive healthcare.
The announcement specifically referenced MetAlert’s suite of wearable technologies, including its patented GPS SmartSole(R) and the RoomMate 3D infrared fall detection system. These products are designed to capture data in real-time, and this data will soon interface with an AI system designed to provide key predictive analytics that can offer invaluable insight into health patterns as well as relevant alerts concerning potential health disturbances and a proactive effort to prevent major medical incidents. “Wearable technology devices are collecting data in real-time all over the world, and adding AI into our technological foundations isn’t merely an evolution — it’s a declaration of our vision, mission and goals to unleash our full value proposition,” said MetAlert CEO Patrick Bertagna in the press release. “Our trajectory isn’t just about keeping pace with wearable tech advancements; it’s about setting our sights on transforming healthcare, delivering a better quality and longevity of life, championing a vision for a healthier, interconnected world and maximizing value for our stakeholders.”
To view the full press release, visit https://ibn.fm/LNT3Z
About MetAlert Inc.
MetAlert and its subsidiaries are engaged in designing, developing, manufacturing, distributing and licensing products, services and intellectual property in the wearable technology, personal location, wandering assistive technology, and health-data collection and monitoring business. MetAlert’s versatile solutions meld effortlessly across a gamut of applications—from consumer-focused products to specialized platforms tailored for enterprise and governmental audiences. With years of experience and an extensive patent portfolio, MetAlert is a leading solution provider for consumers/patients afflicted with Alzheimer’s, dementia and autism. This market represents approximately 2.9% of the world’s population. The company offers global end-to-end hardware, software and connectivity solutions, utilizing the latest in miniaturized, low-power consumption GPS, cellular, RF, NFC and BLE technologies, enabling caregivers to track and monitor patients in real-time. Known for its game-changing and award-winning patented GPS SmartSole(R) — think Dr. Scholl’s meets LoJack, MetAlert and its flagship product stands as the world’s premier invisible wearable monitoring solution, tailor-made for individuals vulnerable to wandering — a boon for caregivers of Alzheimer’s, dementia, autism and traumatic brain injury patients. MetAlert’s subscription-based business model is built around technology innovation with intellectual property protection. The company has international distributors servicing customers across the globe with subscribers in more than 40 countries and is a U.S. military government contractor. Other customers include public health authorities, municipalities, emergency and law enforcement, private schools, assisted living facilities, NGOs, small business enterprises, senior care homes and consumers. For more information about this company, please visit www.MetAlert.com.
NOTE TO INVESTORS: The latest news and updates relating to MLRT are available in the company’s newsroom at https://ibn.fm/MLRT
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork
